NCT03878095 2026-04-08Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting24 enrolled 12 charts
NCT03787680 2026-03-23Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial)University of Michigan Rogel Cancer CenterPhase 2 Active not recruiting49 enrolled 11 charts